Principles & Guidelines
PhRMA Principles & Guidelines
Search PhRMApedia for additional principles and guidelines. PhRMApedia is your new resource hub. You can search our entire database of media preleases, reports, white papers, videos and more. Type your keywords in the search bar and explore PhRMA’s resources. Search results will appear by type, title and date.
PhRMA Principles on Interactions with Health Care Professionals
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents research-based pharmaceutical and biotechnology companies. Our members develop and market new medicines to enable patients to live longer and healthier lives. Read more.
Principles for Responsible Clinical Trial Data Sharing
The Principles reflect the biopharmaceutical sector¹s commitment to responsible data sharing that recognizes the importance of protecting patient privacy, respecting the integrity of national regulatory systems, and maintaining incentives for continued investment in biopharmaceutical research. Read more.
Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results
Developing new therapies to treat disease and to improve quality of life is a long and complex process. A critical part of that process is clinical research, the study of a pharmaceutical product in humans. Without clinical research studies, no new medicines could be made available to patients. Read more.
Principles on DTC Advertising
America’s pharmaceutical research and biotechnology companies understand that accurate information about disease and treatment options makes patients and doctors better partners. And getting that information to patients and consumers is the goal of direct-to-consumer (DTC) pharmaceutical advertising about prescription medicines. Read more.
PhRMA Principles on Interactions with Patient Organizations
Biopharmaceutical companies share many common interests with patient organizations including, most importantly, a common commitment to patients and shared mission to discover cures and fight disease. In our joint mission of innovation and service to patients and caregivers, companies frequently work together with patient organizations to sponsor research, provide educational and support services for patients, and award grants to benefit the mission of patient groups. Read more.
Code on Business Ethics
PhRMA supports the APEC (Asia Pacific Economic Cooperation) Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector. These principles address healthcare and patient focus, integrity, independence, legitimate intent and transparency. Read more.
Health Outcomes Research
PhRMA supports the development of high quality information about patients’ medical treatment options. Empowering patients and physicians with high quality information will help ensure that our health system efficiently delivers the best possible results for all patient. Read more.
Principles on Responsible Sharing of Truthful and Non-Misleading Information About Medicines with Health Care Professionals and Payers
Biopharmaceutical companies are uniquely positioned to help health care professionals achieve the best outcomes for patients, because companies can provide timely, accurate, and comprehensive information about both approved and unapproved uses of the medications they research, develop, and bring to patients. PhRMA and its members believe that the availability of a wider range of truthful and non-misleading information can help health care professionals and payers make better informed medical decisions for their patients, which in turn will benefit patients. Learn more here.